Electrocatalysis of Cu−MOF/Graphene Composite and its Sensing Application for Electrochemical Simultaneous Determination of Dopamine and Paracetamol

A nanocomposite of HKUST‐1 (MOF) and electroreduction graphene oxide (ERGO) is prepared and applied as an electrochemical sensor for the simultaneous determination of paracetamol and dopamine by means of one‐step electrodeposition. The MOF/ERGO composite displays excellent electrochemical catalytic activities towards the paracetamol and dopamine, which is attributed to the synergistic effect of big surface area, porosity and high electrocataytic activity of the MOF and good conductivity of ERGO. The modified electrode could be applied to determine simultaneously paracetamol and dopamine in biochemical samples with wide linear ranges (0.2 μM to 160 μM for paracetamol and 0.2 μM to 300 μM for dopamine) and low detection limits (0.016 μM for paracetamol and 0.013 μM for dopamine). Meanwhile, the proposed sensor still displays high sensitivity, good selectivity and excellent stability.     

Modulating the Biofunctionality of Metal–Organic‐Framework‐Encapsulated Enzymes through Controllable Embedding Patterns

Embedding an enzyme within a MOF as exoskeleton (enzyme@MOF) offers new opportunities to improve the inherent fragile nature of the enzyme, but also to impart novel biofunctionality to the MOF. Despite the remarkable stability achieved for MOF‐embedded enzymes, embedding patterns and conversion of the enzymatic biofunctionality after entrapment by a MOF have only received limited attention. Herein, we reveal how embedding patterns affect the bioactivity of an enzyme encapsulated in ZIF‐8. The enzyme@MOF can maintain high activity when the encapsulation process is driven by rapid enzyme‐triggered nucleation of ZIF‐8. When the encapsulation is driven by slow coprecipitation and the enzymes are not involved in the nucleation of ZIF‐8, enzyme@MOF tends to be inactive owing to unfolding and competing coordination caused by the ligand, 2‐methyl imidazole. These two embedding patterns can easily be controlled by chemical modification of the amino acids of the enzymes, modulating their biofunctionality.     

Enhanced Photodynamic Therapy by Reduced Levels of Intracellular Glutathione Obtained By Employing a Nano‐MOF with CuII as the Active Center

In photodynamic therapy (PDT), the level of reactive oxygen species (ROS) produced in the cell directly determines the therapeutic effect. Improvement in ROS concentration can be realized by reducing the glutathione (GSH) level or increasing the amount of photosensitizer. However, excessive amounts photosensitizer may cause side effects. Therefore, the development of photosensitizers that reduce GSH levels through synergistically improving ROS concentration in order to strengthen the efficacy of PDT for tumor is important. We report a nano‐metal–organic framework (Cu^II‐metalated nano‐MOF {CuL‐[AlOH]₂}_n (MOF‐2, H₆L=mesotetrakis(4‐carboxylphenyl)porphyrin)) based on Cu^II as the active center for PDT. This MOF‐2 is readily taken up by breast cancer cells, and high levels of ROS are generated under light irradiation. Meanwhile, intracellular GSH is considerably decreased owing to absorption on MOF‐2; this synergistically increases ROS concentration and accelerates apoptosis, thereby enhancing the effect of PDT. Notably, based on the direct adsorption of GSH, MOF‐2 showed a comparable effect with the commercial antitumor drug camptothecin in a mouse breast cancer model. This work provides strong evidence for MOF‐2 as a promising new PDT candidate and anticancer drug.     

“Armor‐Plating” Enzymes with Metal–Organic Frameworks (MOFs)

Cell‐free enzymatic catalysis (CFEC) is an emerging biotechnology that enable the biological transformations in complex natural networks to be imitated. This biomimetic approach allows industrial products such as biofuels and biochemical to be manufactured in a green manner. Nevertheless, the main challenge in CFEC is the poor stability, which restricts the effectiveness and lifetime of enzymes in sophisticated applications. Immobilization of the enzymes within solid carriers is considered an efficient strategy for addressing these obstacles. Specifically, putting an “armor‐like” porous metal–organic framework (MOF) exoskeleton tightly around the enzymes not only shields the enzymes against external stimulus, but also allows the selective transport of guests through the accessible porous network. Herein we present the concept of this biotechnology of MOF‐entrapped enzymes and its cutting‐edge applications.     

H2S‐Activable MOF Nanoparticle Photosensitizer for Effective Photodynamic Therapy against Cancer with Controllable Singlet‐Oxygen Release

Photodynamic therapy (PDT) has emerged as an important minimally invasive tumor treatment technology. The search for an effective photosensitizer to realize selective cancer treatment has become one of the major foci in recent developments of PDT technology. Controllable singlet‐oxygen release based on specific cancer‐associated events, as another major layer of selectivity mode, has attracted great attention in recent years. Here, for the first time, we demonstrated that a novel mixed‐metal metal–organic framework nanoparticle (MOF NP) photosensitizer can be activated by a hydrogen sulfide (H₂S) signaling molecule in a specific tumor microenvironment for PDT against cancer with controllable singlet‐oxygen release in living cells. The effective removal of tumors in vivo further confirmed the satisfactory treatment effect of the MOF NP photosensitizer.     

Dinuclear Gold(I) Pyrrolidinedithiocarbamato Complex: Cytotoxic and Antimigratory Activities on Cancer Cells and the Use of Metal–Organic Framework

A dinuclear gold(I) pyrrolidinedithiocarbamato complex ( 1 ) with a bidentate carbene ligand has been constructed and shows potent in vitro cytotoxic activities towards cisplatin‐resistant ovarian cancer cells A2780cis. Its rigid scaffold enables a zinc(II)‐based metal–organic framework (Zn‐MOF) to be used as a carrier in facilitating the uptake and release of 1 in solutions. Instead of using a conventional dialysis approach for the drug‐release testing, in this study, a set of transwell assay‐based experiments have been designed and employed to examine the cytotoxic and antimigratory activities of 1 @Zn‐MOF towards A2780cis.     

Multivariate Modulation of the Zr MOF UiO‐66 for Defect‐Controlled Combination Anticancer Drug Delivery

Metal–organic frameworks (MOFs) are emerging as leading candidates for nanoscale drug delivery, as a consequence of their high drug capacities, ease of functionality, and the ability to carefully engineer key physical properties. Despite many anticancer treatment regimens consisting of a cocktail of different drugs, examples of delivery of multiple drugs from one MOF are rare, potentially hampered by difficulties in postsynthetic loading of more than one cargo molecule. Herein, we report a new strategy, multivariate modulation, which allows incorporation of up to three drugs in the Zr MOF UiO‐66 by defect‐loading. The drugs are added to one‐pot solvothermal synthesis and are distributed throughout the MOF at defect sites by coordination to the metal clusters. This tight binding comes with retention of crystallinity and porosity, allowing a fourth drug to be postsynthetically loaded into the MOFs to yield nanoparticles loaded with cocktails of drugs that show enhancements in selective anticancer cytotoxicity against MCF‐7 breast cancer cells in vitro. We believe that multivariate modulation is a significant advance in the application of MOFs in biomedicine, and anticipate the protocol will also be adopted in other areas of MOF chemistry, to easily produce defective MOFs with arrays of highly functionalised pores for potential application in gas separations and catalysis.     

A Porous Zn2(abct) Framework as an Efficient Carrier for 5‐Fu Delivery and Inhibiting Human Liver Cancer Cells

The creation of effective drug delivery systems is very important in diagnosis and treatment of cancer through controlled and targeted drug delivery. They can increase bioavailability of drugs and reduce their side effects. Metal‐organic frameworks (MOFs) are alternative drug delivery systems, which are suitable for targeted drug delivery due to their adjustable pore sizes and compatibility by adding some functional groups. In this work, a new porous Zn^II‐organic framework was fabricated using a tetracarboxylic acid linker 3,3′,5,5′‐azobenzene‐tetracarboxylic acid (H₄abct), which reveals a 3D channel‐type framework with a high free pore volume. The performance of the solvent‐free samples was studied on absorbing and releasing 5‐fluorouracil (5‐Fu). Characterization methods, such as FT‐IR, PXRD, HPLC, BET measurement, and GCMC simulations, were employed to characterize the 5‐Fu loaded framework. Furthermore, anticancer properties of the MOF and drug‐loaded MOF were investigated against four human liver cancer cells (HepG2, SMMC‐7721, HuH‐7 and MHCC‐97H).     

Highly Mesoporous Metal‐Organic Frameworks as Synergistic Multimodal Catalytic Platforms for Divergent Cascade Reactions

Rational engineering and assimilation of diverse chemo‐ and biocatalytic functionalities in a single nanostructure is highly desired for efficient multistep chemical reactions but has so far remained elusive. Here, we design and synthesize multimodal catalytic nanoreactors (MCNRs) based on a mesoporous metal‐organic framework (MOF). The MCNRs consist of customizable metal nanocrystals and stably anchored enzymes in the mesopores, as well as coordinatively unsaturated cationic metal MOF nodes, all within a single nanoreactor space. The highly intimate and diverse catalytic mesoporous microenvironments and facile accessibility to the active site in the MCNR enables the cooperative and synergistic participation from different chemo‐ and biocatalytic components. This was shown by one‐pot multistep cascade reactions involving a heterogeneous catalytic nitroaldol reaction followed by a [Pd/lipase]‐catalyzed chemoenzymatic dynamic kinetic resolution to yield optically pure (>99 % ee) nitroalcohol derivatives in quantitative yields.     

Immobilizing sulfotransferase 1A1 on magnetic microparticles and their evaluation using capillary electrophoresis

Sulfotransferases are categorized as phase II metabolic enzymes. Human sulfotransferase 1A1 (SULT1A1) is involved in the sulfonation of xenobiotics with aid from the cofactor 3'‐phosphoadenosine‐5'‐phosphosulfate that acts as a sulfonate donor. In this study, we have attempted to immobilize SULT1A1 on magnetic microparticles (MMs). Different functionalized MMs were used to immobilize SULT1A1 and their enzyme activity was compared to the control (enzyme in solution). Paracetamol was used as model substrate. Separation of paracetamol and paracetamol sulfate by CE‐UV was optimized and validated. MMs with epoxy based immobilization of SULT1A1 showed better enzyme activity. Hence, they were tested for repeated usage to allow their implementation for the development of a CE immobilized micro enzyme reactor.     

MOF‐on‐MOF: Oriented Growth of Multiple Layered Thin Films of Metal–Organic Frameworks

The precise alignment of multiple layers of metal–organic framework (MOF) thin films, or MOF‐on‐MOF films, over macroscopic length scales is presented. The MOF‐on‐MOF films are fabricated by epitaxially matching the interface. The first MOF layer (Cu₂(BPDC)₂, BPDC=biphenyl‐4,4′‐dicarboxylate) is grown on an oriented Cu(OH)₂ film by a “one‐pot” approach. Aligned second (Cu₂(BDC)₂, BDC=benzene 1,4‐dicarboxylate, or Cu₂(BPYDC)₂, BPYDC=2,2′‐bipyridine‐5,5′‐dicarboxylate) MOF layers can be deposited using liquid‐phase epitaxy. The co‐orientation of the MOF films is confirmed by X‐ray diffraction. Importantly, our strategy allows for the synthesis of aligned MOF films, for example, Cu₂(BPYDC)₂, that cannot be grown on a Cu(OH)₂ surface. We show that aligned MOF films furnished with Ag nanoparticles show a unique anisotropic plasmon resonance. Our MOF‐on‐MOF approach expands the chemistry of heteroepitaxially oriented MOF films and provides a new toolbox for multifunctional porous coatings.     

A Catalase‐Like Metal‐Organic Framework Nanohybrid for O2‐Evolving Synergistic Chemoradiotherapy

Tumor hypoxia, the “Achilles’ heel” of current cancer therapies, is indispensable to drug resistance and poor therapeutic outcomes especially for radiotherapy. Here we propose an in situ catalytic oxygenation strategy in tumor using porphyrinic metal‐organic framework (MOF)‐gold nanoparticles (AuNPs) nanohybrid as a therapeutic platform to achieve O₂‐evolving chemoradiotherapy. The AuNPs decorated on the surface of MOF effectively stabilize the nanocomposite and serve as radiosensitizers, whereas the MOF scaffold acts as a container to encapsulate chemotherapeutic drug doxorubicin. In vitro and in vivo studies verify that the catalase‐like nanohybrid significantly enhances the radiotherapy effect, alleviating tumor hypoxia and achieving synergistic anticancer efficacy. This hybrid nanomaterial remarkably suppresses the tumor growth with minimized systemic toxicity, opening new horizons for the next generation of theranostic nanomedicines.     

Ruthenium Complexation in an Aluminium Metal–Organic Framework and Its Application in Alcohol Oxidation Catalysis

A ruthenium trichloride complex has been loaded into an aluminium metal–organic framework (MOF), MOF‐253, by post‐synthetic modification to give MOF‐253‐Ru. MOF‐253 contains open bipyridine sites that are available to bind with the ruthenium complex. MOF‐253‐Ru was characterised by elemental analysis, N₂ sorption and X‐ray powder diffraction. This is the first time that a Ru complex has been coordinated to a MOF through post‐synthetic modification and used as a heterogeneous catalyst. MOF‐253‐Ru catalysed the oxidation of primary and secondary alcohols, including allylic alcohols, with PhI(OAc)₂ as the oxidant under very mild reaction conditions (ambient temperature to 40 °C). High conversions (up to >99 %) were achieved in short reaction times (1–3 h) by using low catalyst loadings (0.5 mol % Ru). In addition, high selectivities (>90 %) for aldehydes were obtained at room temperature. MOF‐253‐Ru can be recycled up to six times with only a moderate decrease in substrate conversion.     

A Photodynamic System based on Endogenous Bioluminescence for in vitro Anticancer Studies

Photodynamic therapy (PDT) is becoming an important cancer treatment in recent years. However, at present, the therapeutic effect of PDT is limited due to insufficient penetration depth of light. In this study, a new photodynamic system (d ‐Lu)PCN‐224 is constructed by porphyrin‐based metal‐organic framework (MOF) PCN‐224 and bioluminescent molecule d ‐fluorescein (d ‐Lu). The bioluminescence (BL) spectrum of the reaction overlaps with the absorption spectrum of PCN‐224, so it is speculated that bioluminescence resonance energy transfer (BRET) between the MOF and d ‐Lu which indicates inner light can be gained and used for PDT. Confocal imaging analysis and cytotoxicity assays have demonstrated that (d ‐Lu)PCN‐224 can produce singlet oxygen and decrease the cell viability of SKOV‐3. This system provides a possibility of PDT for deep‐level organization without an external light source.     

Metal–Organic Frameworks Based Electrocatalysts for the Oxygen Reduction Reaction

In view of the clean and sustainable energy, metal–organic frameworks (MOFs) based materials, including pristine MOFs, MOF composites, and their derivatives are emerging as unique electrocatalysts for oxygen reduction reaction (ORR). Thanks to their tunable compositions and diverse structures, efficient MOF‐based materials provide new opportunities to accelerate the sluggish ORR at the cathode in fuel cells and metal–air batteries. This Minireview first provides some introduction of ORR and MOFs, followed by the classification of MOF‐based electrocatalysts towards ORR. Recent breakthroughs in engineering MOF‐based ORR electrocatalysts are highlighted with an emphasis on synthesis strategy, component, morphology, structure, electrocatalytic performance, and reaction mechanism. Finally, some current challenges and future perspectives for MOF‐based ORR electrocatalysts are also discussed.     

A novel biosensor for early diagnosis of liver cancer cases using smart nano‐magnetic metal–organic framework

For the first time, alpha‐fetoprotein (AFP) quantification as an early test for liver cancer diagnosis competing with other interfering analytes and factors based on a novel nano‐magnetic metal–organic framework (MOF) was investigated. The novel nano‐magnetic MOF was synthesized via a simple preparation method, and characterized using various techniques. The X‐ray photoelectron spectrum of the nano‐magnetic MOF shows Cu 2p, O 1s, N 1s and C 1s peaks that evidence the presence of these elements in the sample without any impurities. Scanning and transmission electron microscopy images show the nano‐magnetic MOF with average size between 22 and 43 nm. The results of a photoluminescence study show that the nano‐magnetic MOF exhibits strong emission at 418 nm after excitation at 354 nm. Moreover, a Stern–Völmer graph shows a linear calibration curve over an AFP concentration range 1.0–520 ng ml^?1 with a correlation coefficient of 0.997, detection limit of 1.18 ng ml^?1 and quantitation limit of 3.58 ng ml^?1. According to the marked quenching of the photoluminescence intensity of the nano‐magnetic MOF using various concentrations of AFP, it was successfully used as a biosensor for AFP in serum samples collected from hepatitis patients in addition to healthy males and females. The quenching mechanism was well studied, and found to be a dynamic type. The present work offers a simple, low‐cost, room‐temperature and rapid technique, being non‐time‐consuming, highly accurate, selective and highly sensitive compared with most published methods.     

Crystal Dynamics in Multi‐stimuli‐Responsive Entangled Metal–Organic Frameworks

An understanding of solid‐state crystal dynamics or flexibility in metal–organic frameworks (MOFs) showing multiple structural changes is highly demanding for the design of materials with potential applications in sensing and recognition. However, entangled MOFs showing such flexible behavior pose a great challenge in terms of extracting information on their dynamics because of their poor single‐crystallinity. In this article, detailed experimental studies on a twofold entangled MOF ( f‐MOF‐1) are reported, which unveil its structural response toward external stimuli such as temperature, pressure, and guest molecules. The crystallographic study shows multiple structural changes in f‐MOF‐1 , by which the 3 D net deforms and slides upon guest removal. Two distinct desolvated phases, that is, f‐MOF‐1 a and f‐MOF‐1 b , could be isolated; the former is a metastable one and transformable to the latter phase upon heating. The two phases show different gated CO₂ adsorption profiles. DFT‐based calculations provide an insight into the selective and gated adsorption behavior with CO₂ of f‐MOF‐1 b . The gate‐opening threshold pressure of CO₂ adsorption can be tuned strategically by changing the chemical functionality of the linker from ethanylene (?CH₂?CH₂?) in f‐MOF‐1 to an azo (?N=N?) functionality in an analogous MOF, f‐MOF‐2 . The modulation of functionality has an indirect influence on the gate‐opening pressure owing to the difference in inter‐net interaction. The framework of f‐MOF‐1 is highly responsive toward CO₂ gas molecules, and these results are supported by DFT calculations.     

Electroactive Metal–Organic Frameworks as Emitters for Self‐Enhanced Electrochemiluminescence in Aqueous Medium

Metal–organic frameworks (MOFs) have limited applications in electrochemistry owing to their poor conductivity. Now, an electroactive MOF (E‐MOF) is designed as a highly crystallized electrochemiluminescence (ECL) emitter in aqueous medium. The E‐MOF contains mixed ligands of hydroquinone and phenanthroline as oxidative and reductive couples, respectively. E‐MOFs demonstrate excellent performance with surface state model in both co‐reactant and annihilation ECL in aqueous medium. Compared with the individual components, E‐MOFs significantly improve the ECL emission due to the framework structure. The self‐enhanced ECL emission with high stability is realized by the accumulation of MOF cation radicals via pre‐reduction electrolysis. The self‐enhanced mechanism is theoretically identified by DFT. The mixed‐ligand E‐MOFs provide a proof of concept using molecular crystalline materials as new ECL emitters for fundamental mechanism studies.     

Modulating the Biofunctionality of Metal–Organic-Framework-Encapsulated Enzymes through Controllable Embedding Patterns

Embedding an enzyme within a MOF as exoskeleton (enzyme@MOF) offers new opportunities to improve the inherent fragile nature of the enzyme, but also to impart novel biofunctionality to the MOF. Despite the remarkable stability achieved for MOF-embedded enzymes, embedding patterns and conversion of the enzymatic biofunctionality after entrapment by a MOF have only received limited attention. Herein, we reveal how embedding patterns affect the bioactivity of an enzyme encapsulated in ZIF-8. The enzyme@MOF can maintain high activity when the encapsulation process is driven by rapid enzyme-triggered nucleation of ZIF-8. When the encapsulation is driven by slow coprecipitation and the enzymes are not involved in the nucleation of ZIF-8, enzyme@MOF tends to be inactive owing to unfolding and competing coordination caused by the ligand, 2-methyl imidazole. These two embedding patterns can easily be controlled by chemical modification of the amino acids of the enzymes, modulating their biofunctionality.     

Well‐Defined Metal–Organic Framework Hollow Nanocages

Metal–organic frameworks (MOFs) have demonstrated great potentials in a variety of important applications. To enhance the inherent properties and endow materials with multifunctionality, the rational design and synthesis of MOFs with nanoscale porosity and hollow feature is highly desired and remains a great challenge. In this work, the formation of a series of well‐defined MOF (MOF‐5, Fe^II‐MOF‐5, Fe^III‐MOF‐5) hollow nanocages by a facile solvothermal method, without any additional supporting template is reported. A surface‐energy‐driven mechanism may be responsible for the formation of hollow nanocages. The addition of pre‐synthesized poly(vinylpyrrolidone)‐ (PVP) capped noble‐metal nanoparticles into the synthetic system of MOF hollow nanocages yields the yolk–shell noble metal@MOF nanostructures. The present strategy to fabricate hollow and yolk–shell nanostructures is expected to open up exciting opportunities for developing a novel class of inorganic–organic hybrid functional nanomaterials.